The Golden Jubilee National Hospital marked the 10th anniversary of its Heart and Lung Centre by announcing it has performed almost 100,000 procedures for patients across Scotland since 2008.
Her Majesty the Queen, accompanied by His Royal Highness the Duke of Edinburgh, officially opened the new Heart and Lung Centre on 3 July 2008 as part of NHSScotland’s 60th anniversary celebrations.
The Golden Jubilee Heart and Lung Centre was created following the transfer of regional and national services from Glasgow’s Royal and Western Infirmaries, and Hairmyres Hospital in Lanarkshire.
Bringing the top specialists together under one roof for the first time, it created one of the UK’s largest Heart and Lung Centres.
The service continues to go from strength to strength and has achieved significant and sustained service in 10 short years.
10 years, 100,000 procedures:
- 67,676 diagnostic and interventional cardiology procedures.
- 15,934 cardiac surgery procedures
- 14,181 lung surgery procedures
- 121 Ventricular Assist Device implants (since 2011)
- 104 heart transplants
- 34 babies delivered to 32 mums
10 years of high quality services:
- Currently the second highest volume centre for Coronary Intervention in the UK, providing over 3,000 planned and emergency interventions for patients with coronary artery disease. (British Cardiovascular Intervention Society audit data, 2016)
- Consistently named amongst the top three services in the UK by the Society of Cardiothoracic Surgery in Great Britain and Ireland.
- Continually recognised as having the fastest UK ‘door to balloon’ time for treating heart attacks caused by a blocked artery for 10 years – currently 19 minutes.
- Increased resection rates for lung cancer from 10% to 25% across the West of Scotland, improving survival rates for a large number of patients.
- Introduced minimally invasive keyhole lung surgery, with 80% of procedures now performed using Video Assisted Thoracic Surgery, improving outcomes and reducing length of stay for patients.
- Introduced a pioneering direct referral service for patients experiencing a Non-ST Elevated Mycoardial Infarction (NSTEMI) heart attack.
- Introduced a pioneering nurse-led patient review clinic which allows lung surgery patients to go home sooner.
- 100% of lung cancer cases treated within 31 days and 95% of lung cancer cases treated within 62 days
10 years of innovative ‘firsts’:
- World’s first treatment of a patient with an Implantable Cardioverter Defibrillator using a Magnetic Resonance Imaging scanner.
- First UK hospital to use revolutionary PCI Assist technology to improve outcomes for high risk patients undergoing percutaneous coronary intervention (PCI) for narrowed heart arteries.
- First Scottish hospital to implant a cardioMEMS device which remotely monitors heart failure patients, allowing medications to be altered, reducing the need for hospitalisation and potentially saving lives.
- First use a Subcutaneous Implantable Cardioverter Defibrillator produced outside of America on a patient at risk of sudden cardiac arrest.
- First Scottish hospital to perform minimally Right Anterior Thoracotomy on a patient requiring First Scottish hospital to use MultiPoint Pacing device for administering Cardiac Resynchronisation Therapy in heart failure patients.
- First Scottish hospital to use 3D imaging during keyhole surgery on patients needing treatment for lung cancer.
- First Scottish hospital to perform Video Assisted Thoracic Surgery for Diaphragmatic Plication.
- First Scottish hospital to perform Transcatheter Pulmonary Valve Replacement, avoiding the need for open heart surgery for patients with specific congenital heart problems.
- First Scottish hospital to offer Patient Peer support to cardiothoracic patients, pre or post surgery.
- First Scottish hospital with a dedicated robot for minimally invasive lung surgery operations.
- Developed Scotland’s first ‘One Lung’ training course on single lung ventilation.
10 years, 219 research projects from bench to bedside:
- Pioneering stem cell therapy for patients having a STEMI heart attack.
- Participated in the UK’s first gene therapy trials for heart failure patients, called CUPID2 and SERCA2a, taking place in only two hospitals.
- Played a major role in the ‘PRAMI trial’, finding evidence to suggest that preventative angioplasty following a heart attack has the potential to save the lives of thousands of patients every year.
- Led the T-TIME study to assess a new treatment that is intended to restore blood flow to the small vessels in the heart.
- Found that delayed stenting in patients having a heart attack caused by a blocked artery could reduce the likelihood of ‘no reflow’ and improve outcomes for patients.
Jill Young, Chief Executive of the Golden Jubilee, commented: “As we celebrate the 10th anniversary of our Heart and Lung Centre and the 70th anniversary of the NHS, I would like to offer my sincere thanks to every member of the team who provides first class person centred services to every patient who comes through our doors. They should be very proud of the difference they make to thousands of patients and families across Scotland every year.
“For 10 years our Heart and Lung Centre has been at the forefront of delivering world-leading research and innovations that have improved treatment options for patients across Scotland, the UK and further afield.
“The service has gone from strength to strength over the past 10 years as a direct result of the unparalleled skills, expertise, and dedication shown by every single member of the team every single day, and will continue to do so for the next 10 years and beyond.”
